Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2012

Open Access 01-12-2012 | Research

Validation of the Japanese version of the EORTC hepatocellular carcinoma-specific quality of life questionnaire module (QLQ-HCC18)

Authors: Naoko Mikoshiba, Ryosuke Tateishi, Makoto Tanaka, Tomoko Sakai, Jane M Blazeby, Norihiro Kokudo, Kazuhiko Koike, Keiko Kazuma

Published in: Health and Quality of Life Outcomes | Issue 1/2012

Login to get access

Abstract

Background

This study examined the measurement properties of the Japanese version of the European Organisation for Research and Treatment of Cancer (EORTC) Hepatocellular Carcinoma-Specific Quality of Life Questionnaire (QLQ-HCC18).

Methods

EORTC quality of life (QOL) translation guidelines were followed to create a Japanese version of the EORTC QLQ-HCC18. This was then administered to 192 patients with hepatocellular carcinoma along with the EORTC QLQ-C30 and FACT-Hep questionnaires. Tests for reliability and validity were conducted including comparison of scores between the EORTC and FACT questionnaire and detailed assessment of the new scales and items in clinically distinct groups of patients.

Results

Multi-trait scaling analysis confirmed three putative scales in the QLQ-HCC18, fatigue, fever and nutrition. Cronbach’s alpha for these scales were between 0.68 and 0.78. The QLQ-HCC18 scales correlated with scales measuring similar items in the FACT-Hep and the questionnaire was stable over time with an intra-class correlation score of 0.70 for almost all scales. The questionnaire had the ability to distinguish between patients with different Karnofsky Performance Status, and Child-Pugh liver function class.

Conclusions

The Japanese version of EORTC QLQ-HCC18 is a reliable supplementary measure to use with EORTC QLQ-C30 to measure QOL in Japanese patients with hepatocellular carcinoma.
Literature
1.
Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94: 153–156. 10.1002/ijc.1440CrossRefPubMed
2.
Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005, 55: 74–108. 10.3322/canjclin.55.2.74CrossRefPubMed
3.
Umemura T, Kiyosawa K: Epidemiology of hepatocellular carcinoma in Japan. Hepatol Res 2007, 37(Suppl 2):S95-S100.CrossRefPubMed
4.
Llovet JM, Eurroughs A, Eruix J: Hepatocellular carcinoma. Lancet 2003, 362: 1907–1917. 10.1016/S0140-6736(03)14964-1CrossRefPubMed
5.
Lai MW, Huang SF, Lin SM, Chen TC, Lin CY, Yeh CN, Yer TS, Chen MF, Yeh CT: Expression of the HCRP1 mRNA in HCC as an independent predictor of disease-free survival after surgical resection. Hepatol Res 2009, 39: 164–176. 10.1111/j.1872-034X.2008.00413.xCrossRefPubMed
6.
Lau WY, Lai EC: Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 2008, 7: 237–257.PubMed
7.
Todo S, Furukawa H: Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 2004, 240: 451–459. 10.1097/01.sla.0000137129.98894.42PubMedCentralCrossRefPubMed
8.
de Villa VH, Lo CM, Chen CL: Ethics and rationale of living-donor liver transplantation in Asia. Transplantation 2003, 75(Suppl 3):2–5.CrossRef
9.
Blazeby JM, Currie E, Zee BC, Chie WC, Poon RT, Garden OJ, EORTC Quality of Life Group, EORTC Quality of Life Group: Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18. Eur J Cancer 2004, 40: 2439–2444. 10.1016/j.ejca.2004.06.033CrossRefPubMed
10.
Heffernan N, Cella D, Webster K, Odem L, Martone M, Passik S, Bookbinder M, Fong Y, Jarnagin W, Blumgart L: Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire. J Clin Oncol 2002, 20: 2229–2239. 10.1200/JCO.2002.07.093CrossRefPubMed
11.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al.: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85: 365–376. 10.1093/jnci/85.5.365CrossRefPubMed
12.
Cella DF : Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Scales. Version 4. . Evanston Northwestern Healthcare, Evanston; 1997, .
13.
European Organization for Research and Treatment of Cancer Quality of Life Unit: EORTC quality of life group translation procedure. , ; . [accessed 14 March 2012]. Available from: http://​groups.​eortc.​be/​qol/​downloads/​translation_​manual_​2009.​pdf
14.
Kobayashi K, Takeda F, Teramukai S, Gotoh I, Sakai H, Yoneda S, Noguchi Y, Ogasawara H, Yoshida K: A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer. Eur J Cancer 1998, 34: 810–815. 10.1016/S0959-8049(97)00395-XCrossRefPubMed
15.
Fayers P, Machin D: Quality of life: assessment, analysis and interpretation (second edition). John Wiley and sons, New York; 2009.
16.
Llovet JM, Ricci S, Mazzaferro V, et al.: Sorafenib in advanced hepatocellular carcinoma. New Engl J Med 2008, 24: 378.CrossRef
Metadata
Title
Validation of the Japanese version of the EORTC hepatocellular carcinoma-specific quality of life questionnaire module (QLQ-HCC18)
Authors
Naoko Mikoshiba
Ryosuke Tateishi
Makoto Tanaka
Tomoko Sakai
Jane M Blazeby
Norihiro Kokudo
Kazuhiko Koike
Keiko Kazuma
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2012
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-10-58

Other articles of this Issue 1/2012

Health and Quality of Life Outcomes 1/2012 Go to the issue

Research

The assessment of generalized anxiety disorder: psychometric validation of the Spanish version of the self-administered GAD-2 scale in daily medical practice

Research

Frequency vs. intensity: which should be used as anchors for self-report instruments?

Research

Development of six PROMIS pediatrics proxy-report item banks

Research

Tinnitus assessment by means of standardized self-report questionnaires: Psychometric properties of the Tinnitus Questionnaire (TQ), the Tinnitus Handicap Inventory (THI), and their short versions in an international and multi-lingual sample

Research

Factors associated with non-response in routine use of patient reported outcome measures after elective surgery in England

Research

Long term follow-up of health-related quality of life in young adults born very preterm or with a very low birth weight